Compounds > naltrexone

naltrexone and (r)-n-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine

naltrexone has been researched along with (r)-n-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chubanov, V; Ferioli, S; Gudermann, T; Hofmann, T; Schäfer, S; Zierler, S1
Inoue, H; Konishi, M; Tashiro, M1

Other Studies

2 other study(ies) available for naltrexone and (r)-n-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine

ArticleYear
Mibefradil represents a new class of benzimidazole TRPM7 channel agonists.
    Pflugers Archiv : European journal of physiology, 2016, Volume: 468, Issue:4

    Topics: 1-Naphthylamine; Animals; Calcium; Calcium Channel Blockers; HEK293 Cells; Humans; Magnesium; Mibefradil; Mice; Naltrexone; TRPM Cation Channels

2016
Modulation of Mg
    The journal of physiological sciences : JPS, 2019, Volume: 69, Issue:1

    Topics: 1-Naphthylamine; Animals; Calcium; Cell Line; Cytoplasm; HEK293 Cells; Humans; Magnesium; Male; Myocytes, Cardiac; Naltrexone; Rats; Rats, Wistar; TRPM Cation Channels

2019